Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 1997

View Archived Issues

Company Profile: Kos Pharmaceuticals

Cerebrus uses studies on Redux to design new antiobesity agents

International Murex: Q3 1997 highlights

Confirmatory trials of Alpha-Beta's Betafectin to begin

New agents in development for restenosis

Ganaxolone shows promise in phase II epilepsy and migraine trials

Nycomed Amersham merger now completed

Spotlight on thrombin inhibitors

Fibrinogen antagonists from Merck & Co.

Takeda describes new melatonin agonists

Quinoxalinediones for neurodegenerative/neurological disorders patented

Inhibitors of ECE prepared at Roussel Uclaf/INSERM

Novartis reports protein tyrosine kinase inhibitors for bone disorders

New taxoids from RPR

Preclinical and clinical profile of Searle's fibrinogen antagonist

TP-9201 covered by new U.S. patent

Lamifiban efficacy demonstrated in PARAGON trial

NCI supports R&D on antiangiogenic agents at Telios

Fast-track development of calanolide A as anti-AIDS drug

Prionics develops antibody useful for diagnosing and possibly treating prion diseases

RenaGel with and without calcium effective in ESRD

Efficacy of NC-100100 demonstrated in dogs

SB-234551 prevents radiocontrast-induced renal vasoconstriction in dogs

FDA clears Fortovase

Mechanism of action of triptolide investigated in human T-cells

Fibrinogen receptor occupancy, antiplatelet activity and safety of lefradafiban

LXR to commence pivotal trials with HK-Cardiosol

Phase Ia study with NGD-91-2 completed

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...